CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2022			145,565,916
Beginning balance at Dec. 31, 2022	$ 385,941	$ 11,483	$ 15	$ 1,226,267	$ (840,341)	$ 11,483
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of tax withholding (in shares)			519,868
Stock-based compensation, net of tax withholding	8,209			8,209
Issuance of common stock, net of offering costs (in shares)			28,123,254
Issuance of common stock, net of offering costs	228,835		$ 2	228,833
Series A Preferred Stock accretion to redemption value	(2,121)			(2,121)
Net income (loss)	109,737				109,737
Ending balance (in shares) at Jun. 30, 2023			174,209,038
Ending balance at Jun. 30, 2023	742,084		$ 17	1,461,188	(719,121)
Beginning balance (in shares) at Mar. 31, 2023			167,259,602
Beginning balance at Mar. 31, 2023	683,286		$ 17	1,393,428	(710,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of tax withholding (in shares)			183,357
Stock-based compensation, net of tax withholding	4,341			4,341
Issuance of common stock, net of offering costs (in shares)			6,766,079
Issuance of common stock, net of offering costs	65,540			65,540
Series A Preferred Stock accretion to redemption value	(2,121)			(2,121)
Net income (loss)	(8,962)				(8,962)
Ending balance (in shares) at Jun. 30, 2023			174,209,038
Ending balance at Jun. 30, 2023	$ 742,084		$ 17	1,461,188	(719,121)
Beginning balance (in shares) at Dec. 31, 2023	242,829,391		242,829,391
Beginning balance at Dec. 31, 2023	$ 1,615,921		$ 24	2,183,537	(567,640)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of tax withholding (in shares)			3,320,993
Stock-based compensation, net of tax withholding	78,090			78,090
Issuance of common stock, net of offering costs (in shares)			42,135,953
Issuance of common stock, net of offering costs	834,243		$ 4	834,239
Repurchase of shares in settlement of restricted stock (in shares)			(1,239,758)
Repurchase of shares in settlement of restricted stock	(23,113)			(23,113)
Net income (loss)	$ 137,514				137,514
Ending balance (in shares) at Jun. 30, 2024	287,046,579		287,046,579
Ending balance at Jun. 30, 2024	$ 2,642,655		$ 28	3,072,753	(430,126)
Beginning balance (in shares) at Mar. 31, 2024			268,944,172
Beginning balance at Mar. 31, 2024	2,476,893		$ 27	2,707,333	(230,467)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of tax withholding (in shares)			1,008,225
Stock-based compensation, net of tax withholding	27,049			27,049
Issuance of common stock, net of offering costs (in shares)			17,472,602
Issuance of common stock, net of offering costs	344,950		$ 1	344,949
Repurchase of shares in settlement of restricted stock (in shares)			(378,420)
Repurchase of shares in settlement of restricted stock	(6,578)			(6,578)
Net income (loss)	$ (199,659)				(199,659)
Ending balance (in shares) at Jun. 30, 2024	287,046,579		287,046,579
Ending balance at Jun. 30, 2024	$ 2,642,655		$ 28	$ 3,072,753	$ (430,126)